Origin of measles virus: divergence from rinderpest virus between the 11th and 12th centuries

  • Yuki Furuse1,

    Affiliated with

    • Akira Suzuki1 and

      Affiliated with

      • Hitoshi Oshitani1Email author

        Affiliated with

        Virology Journal20107:52

        DOI: 10.1186/1743-422X-7-52

        Received: 15 January 2010

        Accepted: 4 March 2010

        Published: 4 March 2010


        Measles, caused by measles virus (MeV), is a common infection in children. MeV is a member of the genus Morbillivirus and is most closely related to rinderpest virus (RPV), which is a pathogen of cattle. MeV is thought to have evolved in an environment where cattle and humans lived in close proximity. Understanding the evolutionary history of MeV could answer questions related to divergence times of MeV and RPV.

        We investigated divergence times using relaxed clock Bayesian phylogenetics. Our estimates reveal that MeV had an evolutionary rate of 6.0 - 6.5 × 10-4 substitutions/site/year. It was concluded that the divergence time of the most recent common ancestor of current MeV was the early 20th century. And, divergence between MeV and RPV occurred around the 11th to 12th centuries. The result was unexpected because emergence of MeV was previously considered to have occurred in the prehistoric age.

        MeV may have originated from virus of non-human species and caused emerging infectious diseases around the 11th to 12th centuries. In such cases, investigating measles would give important information about the course of emerging infectious diseases.

        List of Abbreviation


        measles virus


        rinderpest virus


        Time to the Most Recent Common Ancestor






        Measles is a common infection in children and is spread by the respiratory route. It is characterized by a prodromal illness of fever, coryza, cough, and conjunctivitis followed by appearance of a generalized maculopapular rash. Measles virus (MeV) infects approximately 30 million people annually, with a mortality of 197,000, mainly in developing countries [1]. In the prevaccine era, more than 90% of 15-year-old children had a history of measles [2]. Measles remains a major cause of mortality in children, particularly in areas with inadequate vaccination and medical care.

        MeV infection can confer lifelong immunity [3, 4], and there is no animal reservoir or evidence of latent or common persistent infection except for subacute sclerosing panencephalitis (SSPE). Therefore, maintenance of MeV in a population requires constant supply of susceptible individuals. If the population is too small to establish continuous transmission, the virus can be eliminated [5]. Mathematical analyses have shown that a naïve population of 250,000-500,000 is needed to maintain MeV [68]. This is approximately the population of the earliest urban civilizations in ancient Middle Eastern river valleys around 3000-2500 BCE [6, 9, 10]. Historically, the first scientific description of measles-like syndrome was provided by Abu Becr, known as Rhazes, in the 9th century. However, small pox was accurately described by Galen in the 2nd second century whereas measles was not. Epidemics identified as measles were recorded in the 11th and 12th centuries [911].

        MeV is a member of the genus Morbillivirus, which belongs to the family Paramyxoviridae [12]. In addition to MeV, Morbillivirus includes dolphin and porpoise morbillivirus, canine distemper virus, phocid distemper virus, peste des petits ruminants virus, and rinderpest virus (RPV) [12, 13]. Genetically and antigenetically, MeV is most closely related to RPV, which is a pathogen of cattle [12, 14]. MeV is assumed to have evolved in an environment where cattle and humans lived in close proximity [11]. MeV probably evolved after commencement of livestock farming in the early centers of civilization in the Middle East. The speculation accords with mathematical analyses as mentioned above [6, 9, 10].

        Molecular clock analysis can estimate the age of ancestors in evolutionary history by phylogenetic patterns [15, 16]. The basic approach to estimating molecular dates is to measure the genetic distance between species and use a calibration rate (the number of genetic changes expected per unit time) to convert the genetic distance to time. Pomeroy et al. showed that "Time to the Most Recent Common Ancestor" (TMRCA: the age of the sampled genetic diversity) of the current MeV circulating worldwide is recent, i.e., within the last century (around 1943) [17]. Nevertheless, the time when MeV was introduced to human populations has not been investigated until date. In the present study, we performed molecular clock analysis on MeV to determine the time of divergence from RPV, suggesting the evolutionary path of the virus.

        MeV sequences were downloaded from GenBank and aligned using ClustalW. Additional file 1 includes a list of accession numbers for sequences used in this study. Sequences of the hemagglutinin (H) and nucleocapsid (N) genes collected worldwide between 1954 and 2009 were used. The H and N genes were selected for analyses since their sequences are registered commonly. Sequences associated with the persistent disease manifestation SSPE were removed because these were expected to exhibit different evolutionary dynamics [18]. To avoid weighting specific outbreaks, we also excluded sequences that had been collected at the same time and place and that were genetically similar to each other. Consequently, the final data sets comprised 149 taxa with an alignment length of 1830 bp for the H gene and 66 taxa with an alignment length of 1578 bp for the N gene.

        To determine the divergence time between MeV and RPV, sequences of peste des petits ruminants virus [GenBank: FJ750560 and FJ750563] were used to define the root of divergence between MeV and RPV.

        The rates of nucleotide substitutions per site and TMRCA were estimated using the Bayesian Markov chain Monte Carlo (MCMC) method available in the BEAST package [19, 20]. This method analyzes the distribution of branch lengths among viruses isolated at different times (year of collection) among millions of sampled trees. For each data set, the best-fit model of nucleotide substitution was determined using MODELTEST [21] in HyPhy [22]. All models were compared using Akaike's Information Criterion. For both the H and N genes, the favored models were closely related to the most general GTR + Gamma + Inv model. Statistical uncertainty in parameter values across the sampled trees was expressed as 95% highest probability density (HPD) values. Runs were carried out with chain lengths of 100 million and the assumption of an 'exponential population growth' using a 'relaxed (uncorrelated lognormal) molecular clocks' [23]. All other parameters were optimized during the burn-in period. The output from BEAST was analyzed using the program TRACER http://​beast.​bio.​ed.​ac.​uk/​Tracer. BEAST analysis was also used to deduce the maximum a posteriori (MAP) tree for each data set, in which tip times correspond to the year of sampling.

        The Bayesian approach assumed varied rates by branch. Using the Bayesian estimate, our analysis derived a mean evolutionary rate of 6.02 × 10-4 substitutions/site/year for the N gene and 6.44 × 10-4 substitutions/site/year for the H gene (Table 1). Based on this approach by analyses for the N gene, 1921 was estimated to be the TMRCA of the current MeV (Figure 1). Date of divergence between MeV and RPV was 1171. Analyses for the H gene yielded similar results; the TMRCA of the current MeV was 1916. 1074 was estimated to be the date of divergence between MeV and RPV.
        Table 1

        Analysis profiles


        Evolutionary rate, substitutions/site/year (95% HPD)

        TMRCA of the current MeV (95% HPD)

        Time of divergence between MeV and RPV (95% HPD)


        6.02 × 10-4 (3.62, 8.76)

        1921 (1895, 1945)

        1171 (678, 1612)


        6.44 × 10-4 (3.65, 9.25)

        1916 (1889, 1944)

        1074 (437, 1576)

        HPD, Highest probability density

        Figure 1

        Bayesian estimates of divergence time. Maximum a posteriori (MAP) tree of the N gene. Tip times reflect the year of sampling. Internal nodes have error bars of 95% credible intervals on their date.

        Our results indicate that divergence of MeV from RPV occurred around the 11th to 12th centuries. The population size at that time was sufficient for maintaining MeV. However, this result was unexpected because emergence of MeV was previously considered to have occurred in the prehistoric age [6, 7, 9, 10]. Estimation errors seem unlikely since Bayesian approach yielded results which are compatible with other reports. In general, substitution rates between 10-3 and 10-4 substitutions/site/year have been previously estimated for RNA viruses including MeV [17, 24, 25]. Pomeroy et al. also found that the date of divergence of the current MeV was within the last century [17].

        In the prevaccine era, over 90 percent of children is infected with MeV by age 15 [2]. Nevertheless, measles has been rarely described earlier. An increasing number of descriptions of measles in the 11th and 12th centuries may reflect the emergence of MeV in human populations at that time [911]. Linguistic evidence suggests that the disease was recognized before the Germanic migrations but after the fragmentation of the Roman Empire, i.e., between 5th and 7th centuries [10, 11]. This age is still within 95% credible intervals of our results. Alternatively, a common ancestor of MeV and RPV may have caused zoonosis in the past; the archaeovirus can infect both humans and cattle. Even if the earliest urban civilizations in ancient Middle Eastern river valleys (around 3000 to 2500 BCE) were infected by an ancestor of the current MeV, the virus probably had different characteristics from the current MeV.

        Emerging infectious diseases have recently caused significant morbidity and mortality. Many diseases are caused by viruses originating in non-human species [26]: HIV from non-human primates [27]; SARS coronavirus from bats [28]; and the pandemic strain of influenza virus in 2009 from swine [29]. MeV may have originated from non-human species and caused emerging infectious diseases around the 11th to 12th centuries. In such cases, investigating measles would give important information about the course of emerging infectious diseases after their introduction into the human population, from evolutionary and epidemiological perspectives.



        This work was supported by JSPS KAKENHI (19406023). YF is a recipient of a scholarship from Honjo International Scholarship Foundation.

        Authors’ Affiliations

        Department of Virology, Tohoku University Graduate School of Medicine


        1. WHO/UNICEF: WHO/UNICEF Joint Annual Measles Report 2008. 2009.
        2. Langmuir AD: Medical importance of measles. American Journal of Diseases of Children 1962, 103:224–226.PubMed
        3. Black FL, Rosen L: Patterns of measles antibodies in residents of Tahiti and their stability in the absence of re-exposure. Journal of Immunology 1962, 88:725–731.
        4. Nanan R, Rauch A, Kampgen E, Niewiesk S, Kreth HW: A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. Journal of General Virology 2000, 81:1313–1319.PubMed
        5. Black FL: Infectious diseases in primitive societies. Science 1975, 187:515–518.PubMedView Article
        6. Black FL: Measles endemicity in insular populations: critical community size and its evolutionary implication. Journal of Theoretical Biology 1966, 11:207–211.PubMedView Article
        7. Keeling MJ: Modelling the persistence of measles[see comment]. Trends in Microbiology 1997, 5:513–518.PubMedView Article
        8. Conlan AJ, Rohani P, Lloyd AL, Keeling M, Grenfell BT: Resolving the impact of waiting time distributions on the persistence of measles. J R Soc Interface 2009.
        9. Black FL: Measles. In Viral Infections of Humans: Epidemiology and Control. 4th edition. Edited by: Evans AS, Kaslow RA. New York: Plenum Publishing Corporation; 1997.
        10. Griffin DE: Measles Virus. In Fields VIROLOGY. 5th edition. Edited by: Knipe DM, Howley PM. Lippincott Williams & Wilkins; 2007.
        11. McNeil W: Plagues and Peoples. New York: Anchor Press/Doubleday; 1976.
        12. Barrett T: Morbillivirus infections, with special emphasis on morbilliviruses of carnivores. Veterinary Microbiology 1999, 69:3–13.PubMedView Article
        13. McCarthy AJ, Goodman SJ: Reassessing conflicting evolutionary histories of the Paramyxoviridae and the origins of respiroviruses with Bayesian multigene phylogenies. Infect Genet Evol 10:97–107.
        14. Sheshberadaran H, Norrby E, McCullough KC, Carpenter WC, Orvell C: The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies. Journal of General Virology 1986, 67:1381–1392.PubMedView Article
        15. Gojobori T, Moriyama EN, Kimura M: Molecular clock of viral evolution, and the neutral theory. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:10015–10018.PubMedView Article
        16. Bromham L, Penny D: The modern molecular clock. Nature Reviews Genetics 2003, 4:216–224.PubMedView Article
        17. Pomeroy LW, Bjornstad ON, Holmes EC: The evolutionary and epidemiological dynamics of the paramyxoviridae. Journal of Molecular Evolution 2008, 66:98–106.PubMedView Article
        18. Woelk CH, Pybus OG, Jin L, Brown DWG, Holmes EC: Increased positive selection pressure in persistent (SSPE) versus acute measles virus infections. Journal of General Virology 2002, 83:1419–1430.PubMed
        19. Drummond AJ, Nicholls GK, Rodrigo AG, Solomon W: Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data. Genetics 2002, 161:1307–1320.PubMed
        20. Drummond AJ, Rambaut A: BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evolutionary Biology 2007, 7:214.PubMedView Article
        21. Posada D, Crandall KA: MODELTEST: testing the model of DNA substitution. Bioinformatics 1998, 14:817–818.PubMedView Article
        22. Pond SLK, Frost SDW, Muse SV: HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005, 21:676–679.PubMedView Article
        23. Drummond AJ, Ho SYW, Phillips MJ, Rambaut A: Relaxed phylogenetics and dating with confidence. Plos Biology 2006, 4:e88.PubMedView Article
        24. Jenkins GM, Rambaut A, Pybus OG, Holmes EC: Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. Journal of Molecular Evolution 2002, 54:156–165.PubMedView Article
        25. Hanada K, Suzuki Y, Gojobori T: A large variation in the rates of synonymous substitution for RNA viruses and its relationship to a diversity of viral infection and transmission modes[erratum appears in Mol Biol Evol. 2004 Jul;21(7):1462]. Molecular Biology & Evolution 2004, 21:1074–1080.View Article
        26. Wolfe ND, Dunavan CP, Diamond J: Origins of major human infectious diseases. Nature 2007, 447:279–283.PubMedView Article
        27. Hahn BH, Shaw GM, De Cock KM, Sharp PM: AIDS as a zoonosis: scientific and public health implications. Science 2000, 287:607–614.PubMedView Article
        28. Lau SK, Woo PC, Li KS, Huang Y, Tsoi HW, Wong BH, Wong SS, Leung SY, Chan KH, Yuen KY: Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:14040–14045.PubMedView Article
        29. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, et al.: Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009, 459:1122–1125.PubMedView Article

        This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.